Work

A biomaterial-based vaccine eliciting durable tumour-specific responses against acute myeloid leukaemia

Year: 2020

Type: article

Source: Nature Biomedical Engineering

DOI: 10.1038/s41551-019-0503-3

Authors: Nisarg J. Shah, Alexander J. Najibi, Ting-Yu Shih, Angelo S. Mao, Azeem Sharda, David T. Scadden, David J. Mooney

Institutions: Harvard University, University of California San Diego, Harvard Stem Cell Institute, Wyss Institute for Biologically Inspired Engineering, Massachusetts General Hospital

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Science Foundation, U.S. Department of Health and Human Services, Cancer Research Institute, National Institutes of Health, National Heart, Lung, and Blood Institute, National Cancer Institute

Awards: G1153475674, G1286113516, Biomaterial Cancer Vaccines that Generate Patient-Specific Antigen In Situ, G3407714478, MSC Encapsulation with Thin Gel Coating, G4158574285, A defend and destroy approach to curing HIV, 3D Models of Immunotherapy, G9000035810, G9000178855

OpenAlex ID: W2998744763

FWCI: 6.066

Cites: 54

Cited by: 120

Related to: 10